Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1979-12-18
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0306-4603
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:495248-Adult,
pubmed-meshheading:495248-Diazepam,
pubmed-meshheading:495248-Humans,
pubmed-meshheading:495248-Methadone,
pubmed-meshheading:495248-Opioid-Related Disorders,
pubmed-meshheading:495248-Self Administration,
pubmed-meshheading:495248-Substance-Related Disorders,
pubmed-meshheading:495248-Token Economy
|
pubmed:year |
1979
|
pubmed:articleTitle |
Reducing benzodiazepine self-administration with contingent reinforcement.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Controlled Clinical Trial
|